Symbols

CLPT

ClearPoint Neuro·NASDAQ

--(--)

Signals Analysis

Bullish signal 4

Bearish signal 1

Consensus Rating "Strong Buy"

Ample Liquidity

High Gross Profit Margin

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About CLPT

Clearpoint Neuro, Inc.

A global therapy-enabling platform company providing navigation and delivery to the brain

Industry

Healthcare Equipment and Supplies

Established Date

Listing Date

12/09/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

172

Fiscal Year Ends

12-31

Website

www.clearpointneuro.com

Security Type

Common stock

Office address

120 S. Sierra Ave. Suite 100 Solana Beach California 92075

Business

Introduction

ClearPoint Neuro, Inc., was incorporated in Delaware in 1998. The company is a commercial-stage medical device company that develops and sells integrated systems for minimally invasive neurosurgery in the brain. Since its inception, ClearPoint Neuro has been committed to the research and development of the basic technology of MRI-guided intervention, building an intellectual property portfolio and developing commercial applications for its technology. Its business scope has expanded from MRI equipment to operating rooms, providing neurosurgery instrument products, and providing consulting services to pharmaceutical companies. Through subsequent acquisitions, the company expanded its product portfolio into neurocritical care, adding new therapies and technologies for the treatment of cerebral hemorrhage, intraventricular hemorrhage and intracranial fluid management.

Company Financials

EPS

CLPT has released its 2025 Q4 earnings. EPS was reported at -0.26, versus the expected -0.19, missing expectations. The chart below visualizes how CLPT has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

CLPT has released its 2025 Q4 earnings report, with revenue of 10.41M, reflecting a YoY change of 33.96%, and net profit of -7.79M, showing a YoY change of -44.56%. The Sankey diagram below clearly presents CLPT's revenue sources and cost distribution.